François Ringeisen

Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study

Lucia Nogová, Lecia V. Sequist, José Manuel Pérez García et al. · Journal of Clinical Oncology · 2017 · 419 citations

Antitumor Activity, Pathology, Global Phase +17

Analysis of the distribution of binding sites for a tissue-specific transcription factor in the vertebrate genome 1 1Edited by M. Gottesman

François Tronche, François Ringeisen, Marta Blumenfeld et al. · Journal of Molecular Biology · 1997 · 179 citations

Chromatin, Tissue-specific Transcription Factor, M. Gottesman +9

Nuclear localization of protein kinase CK2 catalytic subunit (CK2α) is associated with poor prognostic factors in human prostate cancer

Mathieu Laramas, Dominique Pasquier, Odile Filhol et al. · European Journal of Cancer · 2007 · 150 citations

Medicine, Poor Prognostic Factors, Protein Kinase +8

Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR+, HER2− advanced breast cancer: results from BOLERO-2

Mary Ellen Moynahan, David Chen, Wei He et al. · British Journal of Cancer · 2017 · 133 citations · Full text

A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings

Stéphane Oudard, Olivier Rixe, Benoit Beuselinck et al. · Cancer Immunology Immunotherapy · 2010 · 102 citations · Full text

Vaccination, Cancer Immunosurveillance, Genitourinary Cancer +10